A detailed history of Retirement Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Retirement Group, LLC holds 25 shares of VRTX stock, worth $10,204. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 26 3.85%
Holding current value
$10,204
Previous $10,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$407.69 - $446.08 $407 - $446
-1 Reduced 3.85%
25 $10,000
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $1,715 - $2,053
5 Added 23.81%
26 $10,000
Q2 2023

Aug 15, 2023

BUY
$314.42 - $351.91 $1,572 - $1,759
5 Added 31.25%
21 $7,000
Q4 2022

Feb 15, 2023

BUY
$285.76 - $321.48 $2,286 - $2,571
8 Added 100.0%
16 $5,000
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $4,381 - $4,888
-16 Reduced 66.67%
8 $2,000
Q2 2022

Aug 04, 2022

BUY
$234.96 - $292.55 $1,879 - $2,340
8 Added 50.0%
24 $7,000
Q1 2022

May 06, 2022

BUY
$221.42 - $260.97 $2,657 - $3,131
12 Added 300.0%
16 $4,000
Q4 2021

Feb 09, 2022

BUY
$177.01 - $223.45 $177 - $223
1 Added 33.33%
4 $1,000
Q1 2021

May 04, 2021

BUY
$207.02 - $241.31 $207 - $241
1 Added 50.0%
3 $1,000
Q4 2020

Feb 22, 2021

BUY
$207.01 - $276.09 $207 - $276
1 Added 100.0%
2 $0
Q3 2020

Nov 16, 2021

SELL
$255.65 - $303.1 $2.44 Million - $2.89 Million
-9,531 Reduced 99.99%
1 $0
Q3 2020

Sep 08, 2021

BUY
$255.65 - $303.1 $2.44 Million - $2.89 Million
9,531 Added 953100.0%
9,532 $235,000
Q2 2020

Sep 08, 2021

BUY
$225.48 - $295.8 $225 - $295
1 New
1 $0

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Retirement Group, LLC Portfolio

Follow Retirement Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Group, LLC with notifications on news.